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Background: Several strain-specific Klebsiella pneumoniae virulence determinants have been described, though
these have almost exclusively been linked with hypervirulent liver abscess-associated strains. Through PCR
interrogation of integration hotspots, chromosome walking, island-tagging and fosmid-based marker rescue we
captured and sequenced KpGI-5, a novel genomic island integrated into the met56 tRNA gene of K. pneumoniae
KR116, a bloodstream isolate from a patient with pneumonia and neutropenic sepsis.
Results: The 14.0 kb KpGI-5 island exhibited a genome-anomalous G + C content, possessed near-perfect 46 bp
direct repeats, encoded a γ1-chaperone/usher fimbrial cluster (fim2) and harboured seven other predicted genes of
unknown function. Transcriptional analysis demonstrated expression of three fim2 genes, and suggested that the
fim2A-fim2K cluster comprised an operon. As fimbrial systems are frequently implicated in pathogenesis, we
examined the role of fim2 by analysing KR2107, a streptomycin-resistant derivative of KR116, and three isogenic
mutants (Δfim, Δfim2 and ΔfimΔfim2) using biofilm assays, human cell adhesion assays and pair-wise
competition-based murine models of intestinal colonization, lung infection and ascending urinary tract infection.
Although no statistically significant role for fim2 was demonstrable, liver and kidney CFU counts for lung and urinary
tract infection models, respectively, hinted at an ordered gradation of virulence: KR2107 (most virulent),
KR2107Δfim2, KR2107Δfim and KR2107ΔfimΔfim2 (least virulent). Thus, despite lack of statistical evidence there was a
suggestion that fim and fim2 contribute additively to virulence in these murine infection models. However, further
studies would be necessary to substantiate this hypothesis.
Conclusion: Although fim2 was present in 13% of Klebsiella spp. strains investigated, no obvious in vitro or in vivo
role for the locus was identified, although there were subtle hints of involvement in urovirulence and bacterial
dissemination from the respiratory tract. Based on our findings and on parallels with other fimbrial systems, we
propose that fim2 has the potential to contribute beneficially to pathogenesis and/or environmental persistence of
Klebsiella strains, at least under specific yet-to-be identified conditions.* Correspondence: kr46@le.ac.uk
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Klebsiella pneumoniae is a Gram negative member of the
Enterobacteriaceae family that commonly causes nosoco-
mial pneumonia, bacteriaemia, urinary tract infections
and wound infections [1]. In recent years the treatment
of K. pneumoniae infections has become more challen-
ging due to the greater prevalence of multiple antibiotic
resistant strains [2,3]. Moreover, hypervirulent, pyogenic
liver abscess-causing K. pneumoniae strains that infect
otherwise healthy individuals have emerged from initial
endemic foci in Taiwan and China, and are now spread-
ing into North America and Europe [4-6]. This high-
lights the increasing threat that K. pneumoniae poses to
public health and the importance of elucidating its
mechanisms of pathogenesis.
Most K. pneumoniae strains possess a thick polysac-
charide capsule which is involved in protection from op-
sonisation and phagocytosis and is a well recognized
in vivo virulence factor [7]. Various studies have also
highlighted roles for surface-exposed lipopolysaccharides,
multiple iron acquisition systems and adhesins in
K. pneumoniae infection [1,7,8]. Several strain-specific
virulence determinants of the pyogenic liver abscess-
associated isolate K. pneumoniae NTUH-K2044 have
been well characterised [9-11]. However, the functions of
strain-specific genomic regions in K. pneumoniae strains
associated with other types of infection remain poorly
studied.
Comparative analyses using computational and in vitro
experimental techniques have shown that K. pneumoniae
strains possess an extremely plastic genome that consists
of a conserved core genome interspersed by strain-specific
accessory components [12-15]. This was further high-
lighted in a recent study which calculated that only 54.7%
of known K. pneumoniae genes were shared by three
sequenced isolates (Kp342, MGH78578, NTUH-K2044)
[15]. Genomic islands (GI), typically ranging from 10 kb to
200 kb in size and frequently inserted within tRNA gene
(tRNA) hotspots, comprise a substantial proportion of the
accessory genome. GI acquisition offers an efficient
‘quantum leap’ based route to gaining virulence factors,
antibiotic resistance determinants and/or metabolic path-
ways pre-tailored for the exploitation of new environments
[16,17].
Epidemiological studies have suggested that K. pneumo-
niae infections are preceded by colonization of the gastro-
intestinal tract [18]. Adhesion and colonization are essential
steps in the infection process and are often mediated
by fimbriae, which are small hair-like extensions on the bac-
terial cell surface that can interact with other surfaces via
tip-located adhesin proteins [19]. The majority of environ-
mental and clinical K. pneumoniae isolates are known to
express type 1 fimbriae and type 3 fimbriae, which have re-
cently been classified into the γ1 and γ4-fimbrial subgroupsusing the Nuccio and Bäumler fimbrial classification sys-
tem, which was created from a large scale phylogenetic ana-
lysis of fimbrial usher proteins [20-23]. Recent in vivo
experiments have demonstrated a role for K. pneumoniae
type 1 fimbriae in urinary tract infections [22]. Although
type 3 fimbriae have been shown to enhance biofilm forma-
tion and mediate attachment to bladder epithelium in vitro,
the role of these structures in vivo has yet to be determined
as an isogenic mrk knockout strain was as virulent as its
wildtype parent in murine pneumonia and urinary tract in-
fection models [23,24].
K. pneumoniae type 1 and type 3 fimbriae are both
thought to assemble via the chaperone/usher (CU) assem-
bly pathway which has been characterised in detail for the
archetypal E. coli type 1 and P fimbriae [25]. Some CU fim-
briae, such as the Kpc fimbriae of K. pneumoniae NTUH-
K2044, are encoded by only a subset of strains and are
thought to potentially correlate with tropism towards par-
ticular host tissues and infection types [26]. Many strain-
specific fimbriae are encoded on tRNA gene-associated GIs,
best illustrated by the saf, tcf, sef, std and stb fimbrial oper-
ons of Salmonella enterica serovar Typhi strain CT18. This
latter strain encodes an arsenal of twelve putative
CU fimbrial operons that are hypothesized to correl-
ate with adaptation to the human host [27]. The
genomes of K. pneumoniae Kp342, MGH78578 and
NTUH-K2044 contain nine, eleven and eight CU
fimbrial operons, respectively, though the originally
described type 1 and type 3 fimbrial operons are
common to all three [26]. Apart from the serotype
K1-associated kpc operon, no studies have investi-
gated the in vitro and/or in vivo role of other
K. pneumoniae accessory fimbrial operons. We now
describe the identification, genetic characterization
and initial functional analysis of a novel CU fimbrial
operon (fim2) that is encoded on a previously un-
identified GI, KpGI-5, found inserted within the
met56 tRNA gene of K. pneumoniae strain KR116.
Results
The KpGI-5 genomic island codes for a novel predicted
chaperone/usher fimbrial system
Whilst screening five tRNA gene insertion hotspots in six-
teen clinical K. pneumoniae isolates for strain-specific
DNA using a technique called tRIP-PCR [13,14], we found
that K. pneumoniae KR116 possessed an ‘occupied’ met56
tRNA locus. tRIP-PCR using primers PR601 and PR647,
which were designed to amplify across the met56 tRNA
locus, failed to amplify a product in KR116. Single gen-
ome-specific primer based walking from the conserved
met56 upstream flank yielded ~3 kb of novel sequence.
To capture and sequence this entire strain-specific island,
we tagged the known tRNA-proximal arm of the island
with a kanamycin resistance cassette using allelic exchange.
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was then created and used to isolate kanamycin resistance
cassette-bearing inserts by marker rescue. Two overlapping
fosmids, pJFos-1 and pJFos-4, shown by end-sequencing to
span the entire strain-specific region were sequenced to de-
fine this novel KR116 met56-specific GI that we designated
KpGI-5.
KpGI-5 is a 14.0 kb insertion at the met56 locus of
KR116 with many features in common with typical GIs.
Firstly, the calculated G + C content (44.0%) was much
lower than the corresponding genome averaged values of
K. pneumoniae MGH78578 (57.5%) and Kp342 (57.3%).
Secondly, the island was present downstream of the
K. pneumoniae met56 gene, which is a proven hotspot
for GI integration [15]. And finally, the island possessed
an almost perfect 46 bp direct repeat that corresponded
to the 3’ end of met56. However, no putative integrase or
mobility-associated genes were identified. Open reading
frame (ORF) and BLAST analyses were performed on
the KpGI-5 sequence (Figure 1 and Table 1). The 2.7 kb
segment mapping to the right arm of KpGI-5 was 90%
identical to a region immediately downstream of met56
in K. pneumoniae Kp342 and was predicted to encode
two hypothetical proteins (Orf14 and Orf15), a metallo-
beta-lactamase family protein (Orf16) and a putative
GCN5-related N-acetyltransferase (Orf13). The nucleo-
tide sequence of a 3.4 kb central region did not match
any GenBank entries and coded for three novel proteins;
Orf10 and Orf11 exhibited weak matches to putativeFigure 1 Features of the novel KpGI-5 genomic island in K. pneumoni
the species-conserved upstream flank (UF) and downstream flank (DF) sequ
Closest BLASTP similarities for these and other predicted KpGI-5-encoded p
arrows map to G + C % transitions as indicated by G + C profile. The thin ho
content of the K. pneumoniae MGH78578 genome (57.4%) and the entire K
correspond to the minimum and maximum G + C % calculated over an 80
tRNA-distal (DRD) 46 bp direct repeat (DR) sequences associated with KpGI-regulatory proteins from the bacteria Stigmatella auran-
tiaca DW4/3-1 and Serratia odorifera DSM 4582, re-
spectively. Orf10 also possessed a match to the pfam
domain Trans_reg_C (PF00486) which has been impli-
cated in DNA binding, further suggesting a role for
Orf10 in regulation.
The 7.9 kb left arm of KpGI-5 harboured a novel eight-
gene cluster that exhibited sequence similarity and
organizational-identity to the chromosomally-encoded fim
operons of Citrobacter koseri ATCC BAA-895 (~60%) and
K. pneumoniae C3091 (~51%). This cluster was named
fim2. It encoded homologs of all structural and biosyn-
thesis-associated components of the well-characterized
C3091 type 1 fimbrial system, including a major fimbrial
subunit (Fim2A), three minor fimbrial subunits (Fim2F,
Fim2G and Fim2H), and a chaperone (Fim2C) and usher
(Fim2D) protein [22]. Downstream of fim2H was fim2K
which encoded a FimK homolog that possessed a matching
EAL domain but lacked a FimK-equivalent N-terminal
helix-turn-helix domain. EAL domains have been impli-
cated in the hydrolysis of c-di-GMP, an intracellular mes-
senger that regulates important cellular functions including
different forms of motility, adhesin and exopolysaccharide
matrix synthesis, fimbrial expression and virulence [28-32].
Helix-turn-helix domains are associated with binding to
specific DNA sequences and in the context of EAL do-
main-bearing proteins are hypothesized to modulate the c-
di-GMP hydrolytic activity of these proteins [30]. Amino
acid sequence identities between cognate fim2 and fimae KR116. (A) Genetic organisation of KpGI-5 shown lying between
ences. The eight putative fimbrial genes are labelled fim2A–fim2K.
roteins are described in Table 1. KpGI-5 segments indicated by double
rizontal lines on the G + C % graph represent the average G + C
pGI-5 island (44.0%). The 20.8% and 65.0% G + C content lines
bp window, respectively. (B) Alignment of the tRNA-proximal (DRP) and
5. DRP comprises the 3’ end of met56.















fim2K 1385..528 (858) 285 60% (165/276) C. koseri ATCC BAA-895 Putative EAL domain
protein [ABV14791.1]
1e-94
fim2H 2440..1514 (927) 308 62% (190/308) K. pneumoniae sp15 Fimbrial adhesin (FimH) [ACL13802.1] 1e-101
fim2G 2961..2458 (504) 167 72% (120/167) C. koseri ATCC BAA-895 Minor fimbrial
subunit (FimG) [ABV14789.1]
2e-65
fim2F 3501..2974 (528) 175 79% (138/175) C. koseri ATCC BAA-895 Minor fimbrial
subunit (FimF) [ABV14788.1]
1e-73
fim2D 6073..3515 (2559) 852 82% (689/838) C. koseri ATCC BAA-895 Outer membrane usher
protein (FimD) [ABV14787.1]
0.0
fim2C 6858..6229 (630) 209 92% (190/207) K. variicola At-22 Fimbrial chaperone protein
(FimC) [ADC56706.1]
2e-107
fim2I 7519..6989 (531) 176 82% (139/170) C. koseri ATCC BAA-895 Fimbrial protein (FimI) [ABV14784.1] 2e-80





orf10 9002..8355 (648) 215 37% (24/65) S. aurantiaca DW4/3-1 Putative two component system
regulatory protein [EAU69265.1]
0.019
orf11 9409..10254 (846) 281 28% (77/277) S. odorifera DSM 4582 Putative transcriptional regulatory
protein [EFE96725.1]
3e-20
orf12 10251..10727 (477) 158 29% (38/130) S. odorifera DSM 4582 Hypothetical protein [EFE96270.1] 1e-13
orf13 12266..11694 (573) 190 97% (184/190) Klebsiella sp. 1_1_55 Putative GCN5-related
N-acetyltransferase [EFD84432.1]
1e-106
orf14 12387..12268 (120) 39 100% (39/39) K. pneumoniae 342 Hypothetical protein [ACI07992.1] 1e-12
orf15 12616.. 12359 (234) 77 92% (71/77) K. pneumoniae 342 Hypothetical protein [ACI06987.1] 1e-34
orf16 13342..14187 (846) 281 91% (256/281) K. pneumoniae 342 Metallo-beta-lactamase family
protein [ACI07748.1]
1e-151
a aa, amino acids.
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the C3091 fimB, fimE or fimS invertible promoter switch
could be identified upstream of fim2. K. pneumoniae
KR116 also possessed the species-conserved fim and mrk
operons, as shown by PCR screening for the fimH and
mrkD adhesin genes using primer pairs PR1144-PR1145
and PR1150-PR1151, respectively. Of note, the G +C con-
tent of the fim2 operon (47.7%) was much lower than that
of the K. pneumoniae fim operon (60.8%) and quite distinct
from the G +C content of the four fully sequenced
K. pneumoniae genomes (56.9% – 57.4%).
The KpGI-5 fim2 locus is found within several Klebsiella
spp. and is globally distributed
To determine the prevalence of fim2 in Klebsiella spp., a
total of 162 strains (123K. pneumoniae, 19 undefined
Klebsiella spp., 18K. oxytoca, one K. ornithinolytica and
one K. planticola) isolated from distinct sources were PCR
screened for fim2K using primers PR615-PR616. In total,
21 out of 162 strains (13.0%) were identified to be fim2
positive, including 16K. pneumoniae (16/123 = 13.0%),
three undefined Klebsiella spp. (3/19 = 15.7%) and twoK. oxytoca (2/18 = 11.1%). It must be noted that these spe-
cies designations are based on biochemical species identifi-
cations, which can be problematic in this genus [33].
93.4% (15/16) of fim2-positive K. pneumoniae strains were
also found to be mrk- and fim-positive by PCR analysis.
However, the distribution of the latter were not investi-
gated in other Klebsiella spp. due to recognized species-
specific differences in fim and mrk operon sequences [34].
Further examination suggested that the specimen type
from which strains were obtained was not a predictor of
the presence or absence of fim2 (Table 2). Notably, fim2-
positive strains were not limited to one geographical
area. KR116, the index fim2-positive strain, was isolated
in the United Kingdom, while other fim2-bearing strains
were isolated in Germany, Denmark, USA and China,
suggesting a sporadic but global spread of the fim2 locus.
Fim2 genes are expressed under standard in vitro growth
conditions
Many chaperone/usher operons are poorly expressed
under laboratory conditions [35,36]. To investigate fim2
expression, RNA was isolated from KR2107, a
Table 2 Prevalence of fim2 by specimen type
Total a fim2+ b Percentage c
Ascitic fluid 9 1 11.1%
Biliary fluid 1 0 0%
Blood 48 8 16.7%
Cerebrospinal fluid 2 0 0%
Environmental 11 1 9.0%
Pyogenic liver abscess aspirates 11 0 0%
Nasopharynx 3 0 0%
Sputum 11 1 9.0%
Unknown 20 4 20.0%
Urine 45 5 11.1%
Wound 1 1 100%
All 162 21 13.0%
a Total number of strains tested.
b Total number of strains testing fim2-positive using primers PR615 and PR616.
c Percentage of fim2-positive strains.
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been cultured in LB medium for 16 h (37°C, 200 rpm) and
a cDNA library constructed using random primer-based
RT-PCR. Subsequent PCR analysis of this cDNA library
detected transcripts that corresponded to fim2A, fim2H
and fim2K, while reverse transcriptase-free control reac-
tion mixtures did not yield any products, thus confirming
absence of DNA carryover (Figure 2). Follow-up quantita-
tive-PCR experiments on this KR2107 cDNA library
showed that under the growth conditions examined fim2A
was expressed approximately 30- and 90-fold less than
fimA and mrkA, respectively (data not shown). As PCR
analysis spanning orf10 to fim2A did not yield a product,
whilst that linking fim2H to fim2K produced a specific
band, it would appear that the eight gene fim2 cluster was
expressed as a single transcript and that orf10 gene was
not part of this transcriptional unit (Figure 2). Of note,
transcripts corresponding to fim2A, fim2H and fim2K
were also detected in KR2107 grown at 37°C for 16 h
(200 rpm) in M9 minimal media plus 0.2% glycerol, RPMI
1640, RPMI 1640 plus 10% fetal calf serum and King’s B
medium (data not shown).
Heterologous expression of fim2 does not result in
visualisable host fimbriation
The fim2 locus was PCR-amplified from KR116 and
cloned into the high copy number vector pBluescript II
KS+, the low copy number vector pWSK129 and the
PTRC-bearing vector pJTOOL-7 to create pFim2-HCN,
pFim2-LCN and pFim2-Ptrc, respectively. Each plasmid
was transformed into the afimbriate E. coli strain HB101
and examined by electron microscopy in an attempt to
visualise the putative Fim2 fimbriae. Despite use of mul-
tiple induction methods and over 100 cells being viewedper strain, no definite fimbrial structures could be identi-
fied on the bacterial surfaces examined. Similar results
were obtained when the locus was expressed in a fim2-
negative K. pneumoniae mutant, C3091ΔfimΔmrk. By
contrast, HB101 possessing a pJTOOL-7 derivative with
the fim operon expressed abundant and highly character-
istic type 1 fimbriae on its outer surface. Notably, despite
the absence of detectable fimbriation in E. coli HB101/
pFim2-Ptrc induced with IPTG, major induction-asso-
ciated growth reduction was observed (Figure 3A).
HB101/pFim2-Ptrc growth inhibition exhibited a distinct
dose–response relationship to IPTG concentration and
this was not evident with the control strains HB101 and
HB101/pJTOOL-7 (Figure 3B). By contrast, over-expres-
sion of fim appeared to enhance the growth rate of
HB101/pFim-Ptrc but had no effect on final cell densities
as compared to the above mentioned control strains.Expression of fim2 in E. coli HB101 appears to enhance
biofilm formation
K. pneumoniae readily colonizes and forms biofilms on
abiotic surfaces such as urinary catheters and tracheal
tubes [21,37]. As surface-expressed structures play a key
role in biofilm formation, the ability of KR2107 and its iso-
genic mutants to form biofilms was examined. However,
absence of fim2 and/or fim had no effect on biofilm forma-
tion as assayed at 24 h under static growth conditions in
LB or M9 media at either 37°C or 30°C (Figure 4A; data
not shown). To detect a potential contribution to biofilm
formation that may have been masked by low-level fim2
expression or capsule-related physical hindrance of fimbrial
function [38], fim2 was over-expressed from pFim2-Ptrc in
E. coli HB101 using 0.05 mM IPTG induction. Compared
to HB101 carrying the empty pJTOOL-7 vector, HB101/
pFim2-Ptrc exhibited similar biofilm formation at 48 h on
polystyrene wells as assessed by post-washing crystal violet
staining (Figure 4B). On the other hand, expression of fim2
in HB101 resulted in marginally denser biofilm in polyvinyl
chloride wells as compared to the vector-only control, but
this was not statistically significant (P = 0.464; Figure 4B).
As HB101/pFim2-Ptrc grew to a much lower OD595 at
48 h than the other two strains, we also analysed the bio-
film data as a ratio of crystal violet staining intensity to the
pre-wash OD595 measurement that reflected total growth.
This analysis suggested that the proportion of HB101/
pFim2-Ptrc cells comprising biofilm growth as opposed to
total growth (biofilm and planktonic cells) was almost
twice that of HB101 and the vector only control strain
(Figure 4C). Indeed, based on this ratio, fim2 expression in
HB101 exerted a highly significant positive impact on bio-
film formation on both surfaces (P< 0.0001 in each case).
By contrast when fim2 was expressed in the Mrk- and
Fim-deficient strain C3091ΔfimΔmrk using this same
Figure 2 Transcriptional analysis of fim2. A schematic map of the fim2 cluster and the upstream orf10 gene to show regions targeted for
transcriptional analysis: fim2K (PCR-1, 220 bp: PR1611/PR1612), fim2H-fim2K (PCR-2, 316 bp: PR16268/PR1629), fim2H (PCR-3, 241 bp: PR1609/
PR1610), fim2A (PCR-4, 221 bp: PR1607/PR1608) and fim2A-orf10 (PCR-5, 380 bp: PR1626/PR1627). RNA purified from an in vitro grown culture of
KR2107 (LB, 37°C, 200 rpm, 16 h) was processed in parallel with (+) or without (−) reverse transcriptase and analysed by PCR with the primers
listed above. KR2107 genomic DNA (g) and PCR-grade water (Neg) were used as PCR controls when necessary. Amplicons were visualised on 1.5%
agarose gels. Distinct PCR amplicons were obtained for four of the five assays. The PCR-5 assay which sought to define a shared orf10 and fim2A
transcript was negative.
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formation on either surface was observed (data not
shown).
Deletion of fim2 does not affect adhesion to human HCT-8
ileocaecal or 5637 bladder epithelial cells
In vitro adhesion assays were performed to further inves-
tigate whether KR2107 and its three isogenic mutants
(KR2107Δfim, KR2107Δfim2 and KR2107ΔfimΔfim2)
exhibited differing cell adhesion properties. HumanFigure 3 IPTG induction of HB101/pFim2-Ptrc causes a major growth
vector), HB101/pFim-Ptrc and HB101/pFim2-Ptrc. The growth curves for HB
similar. (B) Growth curves for HB101/pFim2-Ptrc grown for 24 h in LB broth
or 0.1 mM IPTG. Data shown in all cases represent the means of two biologHCT-8 ileocecal and human 5637 bladder epithelial cell
lines were chosen to investigate adherence to intestine-
and bladder-derived cells, respectively. No significant dif-
ferences were detectable by these in vitro tissue culture
assays (Figure 5). Furthermore, despite the previously
reported impaired urovirulence of a fim-negative K. pneu-
moniae strain [22], the KR2107Δfim and KR2107ΔfimΔfim2
mutants examined in this study did not display any defect
in adherence to bladder epithelial cells relative to KR2107
or KR2107Δfim2. It is possible that fim and/or fim2reduction. (A) Growth curves for HB101, HB101/pJTOOL-7 (empty
101 and HB101/pJTOOL-7 are largely superimposed as these are very
containing 100 μg/ml ampicillin supplemented with 0.0 mM, 0.05 mM
ical replicates, each assayed in seven wells (n = 14).
Figure 4 The fim2 locus appears to contribute to biofilm
formation when expressed in E. coli HB101. (A) Results for biofilm
formation assay on polystyrene for KR2107 and its three fim and/or
fim2 isogenic mutants as determined by crystal violet absorbance data.
Equivalent results, suggestive of no strain-to-strain differences, were
obtained for assays on polyvinyl chloride plates (data not shown). (B)
Biofilm formation assay based on heterologous expression of fim2 in E.
coli HB101/pFim2-Ptrc. HB101 and HB101 carrying an empty pJTOOL-7
served as controls. Biofilm formation was quantified using crystal violet
staining and absorbance was measured at 595 nm. Non-normalized
crystal violet absorbance data are shown. (C) Biofilm formation assay
results shown in (B) were normalized to take account of pre-wash total
cell numbers based on OD595 readings performed at 48 h, just prior to
washing off non-surface adherent cells and crystal violet staining. Data
shown in all cases represent means and standard deviations of three
biological replicates, each assayed in eight wells (n = 24). An asterisk
indicates a highly significant difference (P< 0.0001) from HB101 and
HB101/pJTOOL-7.
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used or that the K. pneumoniae capsule interfered with fim-
brial function [38,39].
Deletion of fim2 does not affect murine intestinal
colonization
Epidemiological studies have elucidated that the first step
in the majority of K. pneumoniae infections is gastrointes-
tinal tract colonization [18]. To investigate whether fim2
influences this initial step, a 1:1 mixture of KR2107 and
KR2107Δfim2 was fed to three mice and faecal CFU counts
were monitored for 13 days. To exclude potential type 1
fimbriae-related masking, a competition experiment be-
tween KR2107Δfim and KR2107ΔfimΔfim2 was also per-
formed. As assessed by faecal CFU counts, no strain
exhibited an obvious competitive advantage and all four
strains were found to readily colonize the large intestine in
similar numbers (~108 – 109 CFU/g) throughout the ex-
periment (Figure 6). Apart from confirming that fim does
not affect intestinal colonization [22], these results also sug-
gested that fim2 does not play a significant role in murine
intestinal colonization by K. pneumoniae.
The fim2 locus is not a virulence factor in a murine lung
infection model
K. pneumoniae is a clinically important cause of lung
infections and various potential virulence factors have been
determined [40,41]. The influence of fim2 on pneumoviru-
lence was investigated by intranasal inoculation of five
mice with a mixture comprising equal numbers of KR2107
and KR2107Δfim2. An equivalent competition experiment
between KR2107Δfim and KR2107ΔfimΔfim2 was also per-
formed. 30 h post-infection all mice displayed significant
signs of disease and were sacrificed. High numbers of K.
pneumoniae were found in the lungs of all mice (5 × 105 –
1 × 107 CFU/lung). Similar lung CFU counts were obtained
for both competition assays. Furthermore, no significant
deviation in fim2-positive to fim2-negative strain ratios was
evident for either competition assay (Figure 7A). These
data suggest that both fim and fim2 do not impact signifi-
cantly on pneumovirulence of K. pneumoniae in a murine
lung infection model.
Total liver and spleen CFU counts were used as a measure
of the ability of bacteria to disseminate from the lungs into
the bloodstream. Much lower numbers and greater mouse-
to-mouse variation occurred in CFU counts for the livers
(<15 – 1.6 × 104) and spleens (<20 – 200) of these mice.
The median CFU count per liver for KR2107 (2.1 × 103) was
elevated compared to that of KR2107Δfim2 (3.0 × 101), al-
though this difference was not significant (P = 0.340). When
liver CFU counts were examined individually for each
mouse, two mice exhibited greater than 1-log more KR2107
than KR2107Δfim2, while the difference, though still hinting
at an advantage for KR2107, was less than 0.5 log for two
Figure 5 Cell-adherence properties of K. pneumoniae KR2107 and its isogenic fim and/or fim2 mutants. (A) In vitro adhesion assays to
human HCT-8 ileocaecal cells. (B) In vitro adhesion assays to human 5637 bladder epithelial cells. In both cases percentages of bacteria that remained
adherent to cell monolayers after 3 h of incubation at 37°C followed by careful washing are shown. Bars represent means and standard deviations.
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mouse 3 for both strains were equal to the lower limit of de-
tection and extrapolated from a single colony each, thus
preventing meaningful comparison of these values. No dif-
ference was found between the median CFU counts per liver
for KR2107Δfim and KR2107ΔfimΔfim2 (1.5 × 101). Thus,
despite the absence of firm conclusions emanating from
these data, the possibility that fim2 may play a role in sys-
temic dissemination and/or survival of K. pneumoniae fol-
lowing murine lung infection cannot be dismissed entirely.
Role of fim2 in a murine urinary tract infection model
Type 1 fimbriae are a well-established virulence factor of
K. pneumoniae urinary tract infections [22,23]. To assess
the role of fim2 in K. pneumoniae urinary tract infection, a
group of six mice were inoculated transurethrally with a
1:1 mixture of KR2107 and its fim2 mutant and sacrificedFigure 6 Murine intestinal colonization of K. pneumoniae KR2107 and
following oral feeding with a 1:1 mixture of KR2107 and KR2107Δfim2. (B) I
KR2107Δfim and KR2107ΔfimΔfim2. Mean CFU/g faeces and corresponding3 days post-inoculation. All urine and bladder samples
were found to be colonized and a median CFU count of
8.7 × 105 per bladder and 5.0 × 104 per ml of urine was
obtained. In all mice the infection had ascended into the
kidneys producing a median bacterial count of 5.3 × 103
per kidney (n = 12). The median CI value obtained for
bladder samples indicates 10-fold more CFUs of KR2107
than the fim2 mutant (Figure 8A). These values are sup-
ported by the median kidney CFU count which was 10-fold
higher for the wildtype (4.8 × 103) than the fim2 mutant
(4.8 × 102), although this difference is not statistically sig-
nificant (P = 0.285) (Figure 8B). Nevertheless, these con-
cordant findings would suggest that fim2 may exert a
subtle influence on the urovirulence of K. pneumoniae.
To investigate potential genetic redundancy or functional
masking between fim and fim2, the competition assay was
repeated in a fim-negative background. Consistent withits isogenic fim and/or fim2 mutants. (A) Intestinal co-colonization
ntestinal co-colonization following oral feeding with a 1:1 mixture of
standard deviation values are shown.
Figure 7 Murine lung infection model studies with KR2107 and its isogenic fim and/or fim2 mutants. (A) Comparison of the ability of
KR2107 and its isogenic mutants to infect the lungs as assessed by two head-to-head competition assays. A mixture containing an equal ratio of
each competing strain was inoculated intranasally into five mice. The competitive index (CI) is the ratio of the number of fim2-positive to fim2-
negative bacteria recovered from infected organs divided by the equivalent ratio as present in the intranasal inoculum. (B) Differential CFU counts
for each of the competing strains in the liver at 30 h post-inoculation. (C) Liver CFU counts obtained in the five mice used for the competition
assay between KR2107 and its isogenic fim2 mutant. In A and B, horizontal bars represent the median, with data points for each mouse as
indicated. The lower limit of detection is represented by the dotted line. P values were calculated using the Mann–Whitney U test.
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lower in this fim-negative background experiment as com-
pared to the initial competition assay. Infection was estab-
lished in the bladders of five out of six mice, with a median
bacterial count of 1.35 × 102 in these five mice. At time of
sacrifice, infection had ascended into nine of ten kidneys
with a median CFU count of 2.7 × 102 (n = 10). However,
in all cases no bacteria were isolated from the urine sug-
gesting counts of less than 50 per ml. The median CI value
obtained for bladder samples showed that CFU counts for
KR2107Δfim and KR2107ΔfimΔfim2 did not differ signifi-
cantly (Figure 8A). However, the median kidney CFU
counts were 5.6-fold higher for the KR2107Δfim (1.4 × 102)
than KR2107ΔfimΔfim2 mutant (2.5 × 101), and although
similar to the results obtained in the fim-positive back-
ground these results were also not statistically significant
(P = 0.066) (Figure 8B). These results have confirmed the
importance of fim in K. pneumoniae-mediated uroviru-
lence and further support the case for a potential but subtle
accessory role for fim2 in this disease process.
Discussion
The plastic nature of K. pneumoniae genomes is well
described and an increasing number of studies have elu-
cidated the function of various components of the
accessory genome of the pyogenic liver abscess-associated
strain K. pneumoniae NTUH-K2044. However, functional
characterization of the accessory genome of strains asso-
ciated with other types of infection is lacking. In order to
investigate the plasticity of K. pneumoniae associated with
other infections, we previously interrogated the pheV locus
of sixteen clinical isolates from patients without pyogenic
liver abscesses for the presence of foreign DNA elements
[13]. In this study, further tRIP-PCR interrogation ofK. pneumoniae KR116 using met56-specific primers identi-
fied a novel GI, KpGI-5, inserted within its met56 gene.
KR116 had been isolated from the blood of a patient with
pneumonia and neutropenic septicaemia. KpGI-5 was
sequenced in this study and found to encode a putative γ1-
type CU fimbrial operon that has been named fim2.
The genetic organization of fim2 resembles that of the
K. pneumoniae fim operon and contains homologs of all
eight fim genes. fim2 is predicted to code for a major
fimbrial subunit (Fim2A), three minor fimbrial subunits
(Fim2F, Fim2G, Fim2H) and homologs of the FimC and
FimD chaperone and usher proteins, respectively, thus
classifying this locus as a novel γ1-type CU operon that
putatively encodes a fimbrial appendage [20]. A seventh
predicted protein, Fim2I, exhibited 82% identity to FimI,
a protein required for fimbrial biogenesis; however, the
exact nature of this dependence remains unknown [42].
Amino acid sequences of the eight fim2 gene products
showed 60 to 92% identity to cognate Fim proteins. In-
deed, the two clusters would appear to be pseudoparalogs,
homologs that appear to be paralogous but have ended up
in the same genome by both vertical and horizontal gene
transfer [43]. The unique evolutionary origins of the fim
and fim2 cluster are further highlighted by differences in
transcriptional control. The fim cluster is largely controlled
by the FimB and FimE recombinases which together
switch transcription on and off by inverting a 314 bp pro-
moter-containing sequence called fimS that lies upstream
of fimA [22]. Exact copies, genetic remnants or potential
functional-replacements of the 9 bp fimS-flanking inverted
repeats could not be identified within the putative fim2
promoter region that lies upstream of fim2A. Furthermore,
as KpGI-5 lacks homologs of the FimB and FimE recombi-
nases we conclude that fim2 expression is not controlled
Figure 8 Murine urinary tract infection model studies with
KR2107 and its isogenic fim and/or fim2 mutants. (A)
Comparison of the urovirulence of KR2107 and its isogenic mutants
as assessed by two head-to-head competition assays. A mixture
containing approximately equal numbers of each competing strain
was inoculated into the bladders of six mice. The competitive index
(CI) is the ratio of the number of fim2-positive to fim2-negative
bacteria recovered from urine or bladder divided by the equivalent
ratio as present in the infecting inoculum. (B) Differential CFU counts
for each of the competing strains in the left and right kidneys at
3 days post-inoculation. In both of the above analyses horizontal
bars represent the median, with data points for each mouse as
indicated. The lower limit of detection is represented by the dotted
line. P values were calculated using the Mann–Whitney U test.
van Aartsen et al. BMC Microbiology 2012, 12:59 Page 10 of 16
http://www.biomedcentral.com/1471-2180/12/59via a fimS-like switch mechanism. Additionally, the fim2K
gene within the fim2 cluster encodes an EAL domain-
containing protein that is similar to FimK, which has
previously been shown to regulate type 1 fimbrial expres-
sion [31]. FimK was hypothesised to exert its influence via
the hydrolysis of the intracellular messenger c-di-GMP,which is known to regulate expression of virulence genes,
motility and biofilm formation in other bacteria [29]. The
in vitro and in vivo function of Fim2K is currently under
investigation.
Bacterial adhesion to and colonization of host cells is
frequently mediated by a diverse assortment of afimbrial
and fimbrial adhesins, each thought to possess a particular
tissue tropism [19]. The vast majority of K. pneumoniae
strains are able to produce type 1 fimbriae [37,44]. These
structures are associated with mannose-sensitive agglutin-
ation of guinea pig red blood cells, a phenotype caused by
interaction of the adhesin subunit FimH with terminally-
exposed mannose residues in N-linked oligosaccharides on
cell surfaces [45]. Previously it has been shown that the
FimH residues partaking in binding to mono- and tri-man-
nose moieties are highly conserved [45]. The specific bind-
ing properties of Fim2H, the putative Fim2 adhesin,
remain to be identified but it is unlikely to bind to man-
nose since only four out of the 13 mono- and tri-mannose
binding residues of FimH are strictly conserved in Fim2H
[45]. This is also in agreement with the inability of E. coli
HB101 expressing fim2 to agglutinate guinea pig red blood
cells (data not shown), though the relevance of these data
remain uncertain given the lack of visualisable fimbriae in
this model.
Despite multiple attempts we were unable to visualize
fimbrial structures using electron microscopy when the
fim2 operon was over-expressed in E. coli HB101 and K.
pneumoniae C3091ΔfimΔmrk. Paradoxically, biofilm form-
ing ability appeared to be enhanced in this fim2-expressing
E. coli strain. These results are similar to those of a study
in which constitutive expression of four of seven E. coli CU
fimbrial operons was shown to cause phenotypic alterna-
tions despite the fact that fimbrial appendages could not be
visualized by electron microscopy [36]. Difficulty in visual-
isation of fimbriae by electron microscopy has also been
described for the enterotoxigenic E. coli fimbriae CS3 and
CS6 and the putative Stg fimbriae of Salmonella enterica
serovar Typhi [46-48]. Most interestingly, when the latter
was expressed in a bald E. coli strain an enhanced ability to
adhere to INT-407 epithelial cells was noted despite the
absence of EM-observable fimbriae [48]. It is possible that
the fim2 operon may code for a short and/or thin fimbrial
structure that is not readily visualized by electron micros-
copy, or one that is extremely fragile. Conceivably, the
hypothesized Fim2 appendages may be best expressed
under biofilm-forming conditions, potentially explaining
the enhanced biofilm-forming phenotype exhibited by
HB101/pFim2-Ptrc, or in other specific in vivo environ-
ments. Alternatively, the putative phosphodiesterase
Fim2K may regulate fim2 transcription and/or that of an
unknown E. coli adherence factor via a c-di-GMP-
dependent pathway. Indeed, heterologous expression of
fim2K has been shown to complement a mutant lacking an
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lished data). Proposed future anti-Fim2A-based immuno-
fluorescence and immunogold electron microscopy studies
in addition to detailed characterisation of Fim2K will ul-
timately help determine the mechanism by which fim2
contributes to biofilm formation.
The genomes of E. coli K-12, E. coli O157:H7 and Sal-
monella Typhi possess numerous cryptic CU fimbrial
operons that are tightly regulated and not expressed
under the majority of in vitro conditions tested
[35,36,49]. In this work, fim2-specific transcript was
identified in standard laboratory culture but the amount
detected was 30- to 90-fold lower than that identified for
fim and mrk, respectively. Compared to the K. pneumo-
niae genome-averaged A + T content (~43%), fim2 is AT-
rich (53%) and the putative promoter region upstream of
fim2A possesses an even higher AT-content (73%). As
moderate-to-marked upregulation of seven CU fimbrial
operons has been reported in an E. coli K-12 H-NS mu-
tant [36], the finding of an AT-rich fim2 promoter region
suggests that the H-NS protein may play a role in con-
trolling this operon as well. Moreover, H-NS has been
shown to bind preferentially to regions of horizontally-
acquired DNA in Salmonella Typhimurium and it is
therefore possible this also occurs with KpGI-5 [50]. Fur-
thermore, in addition to Fim2K, KpGI-5 also encodes
two other potential regulators one or more of which
could alter fim2 expression. By analogy with other CU
systems, we propose that upregulation of fim2 expression
and biosynthesis of Fim2 fimbriae is likely to be triggered
by specific environmental conditions and involve a com-
plex interplay of multiple transcriptional regulators such
as H-NS, Fim2K and/or FimK, and levels of expression
of other surface components, such as the capsule
[31,36,38,51]. It is important to note that even though
fim2 lacks an invertible promoter switch, it may still be
stochastically controlled by a bistable regulatory circuit
such as the DNA methylation-based system described in
detail for E. coli Pap fimbriae and it is therefore possible
that single cell variants expressing fim2 may exist [51].
Analysis of three sequenced K. pneumoniae strains
revealed that, in addition to the fim and mrk operons,
these genomes collectively encode at least six other CU
fimbrial systems [22,23], one or more of which may per-
form an as-yet uncharacterised role in adhesion to target
tissues. To investigate the role of fim2 in virulence, iso-
genic fim2 mutants were constructed and examined in
three murine models, each focussed on primary infection
of a distinct clinically-relevant anatomical site. Surpris-
ingly, despite many fimbrial systems having been clearly
implicated in virulence, we detected no clear evidence of
attenuation (murine lung and urinary tract infection mod-
els) or reduction in colonizing ability (murine intestinal
colonization model) in the fim2-negative strains studied.Intriguingly, examination of bladder CFU count-based
CIs for the urinary tract infection experiments hinted at
a subtle role for fim2 in the colonization of bladder and
kidney tissues. In both tissues, median wildtype CFU
counts were approximately ten-fold higher than those of
the fim2 mutant, although when performed in a fim
negative background this difference was reversed and
reduced in bladder and kidney samples, respectively.
Nevertheless, the latter conflicting results may due to the
markedly lower CFU counts obtained in the fim negative
background. As shown by neutral CI values in the lung
tissue but an approximately 100-fold higher median liver
CFU count for KR2107 as compared to its isogenic fim2
mutant, the fim2 locus would appear to be involved in
systemic dissemination and/or survival of K. pneumoniae
following primary infection of the respiratory tract. How-
ever, given the noted lack of statistical significance, low
numbers of mice examined and substantial mouse-to-
mouse variation for these liver CFU data, no firm con-
clusions can be derived at present. As an aside, the previ-
ously demonstrated dramatic positive contribution of fim
to urovirulence in this murine model was also shown to
be the case in the KR2107 background [22,23]. At an
overview level, based on total CFU counts per liver and
per kidney for the lung infection and ascending urinary
tract infection models, respectively, there was a sugges-
tion, though not supported statistically, of an ordered
gradation amongst the four isogenic strains with the
most-to-least virulent as follows: KR2107, KR2107Δfim2,
KR2107Δfim and KR2107ΔfimΔfim2. We speculate this
relates to a Fim2-mediated enhancement of bacterial bio-
film-forming-, adhesive- and/or invasive-potential under
the in vivo conditions tested. In addition, the predicted
influence of Fim2K on the c-di-GMP regulatory circuit,
may itself impact on virulence via regulation of Fim2,
Fim and/or other virulence factors.
The fim2 cluster was also assessed for its ability to con-
tribute to biofilm formation. Gene knock-out experiments
in KR2107 failed to reveal a role for fim2 in biofilm forma-
tion. However, the function of the product of fim2 may
have been masked due to physical interference by the K.
pneumoniae capsule, a phenomenon previously observed
with type 1 fimbriae [38,39]. Alternatively, it may be a
function of limited fim2 expression under the in vitro con-
ditions examined. Therefore, heterologous expression of
fim2 in the afimbriate E. coli strain HB101 and the bald
fim2-negative K. pneumoniae C3091ΔfimΔmrk mutant
was pursued. Yet again evidence of a fim2-associated
phenotype was elusive and only apparent in HB101 and
then too only when crystal violet-staining data were stan-
dardised for total pre-wash cell numbers. Attempts to alle-
viate the observed growth retardation associated with
over-expression of fim2 in a HB101 background by redu-
cing incubation temperature to 30°C and by providing rare
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observed growth retardation was highly reproducible even
when newly generated HB101 strains possessing independ-
ently-constructed pFim2-Ptrc plasmids were used instead
(van Aartsen and Rajakumar, unpublished data). Thus, it
would appear that over-expression of fim2 in HB101 was
specifically responsible for this phenotype, though no com-
parable effect occurred with over-expression of fim.
The presence of fim2 in more than one species and its
global spread suggests that this horizontally acquired
locus has been maintained within a subset of the Klebsi-
ella population due to positive selection. Hence, al-
though the role fim2 remains elusive, given the glimpses
of functionality hinted at by our data and the evolution-
ary survival of this multi-gene entity, we hypothesize that
putative Fim2 contributes to pathogenesis of infection
and/or environmental persistence, at least under highly
specific conditions.
Conclusions
In conclusion, we have described the KpGI-5 island
which possessed a novel γ1-type CU operon called fim2.
Although fim2 was shown to be expressed at an mRNA
level and its function was investigated using three dis-
tinct murine infection models, tissue culture experiments
and biofilm assays, no obvious in vitro or in vivo role for
the fim2 locus was identified, although there were subtle
hints of involvement in urovirulence and in bacterial dis-
semination from the respiratory tract. Nevertheless, as
fim2 was found in approximately 13% of Klebsiella spp.
isolates examined, we propose that fim2 has the potential
to contribute beneficially to its host Klebsiella strains at
least under specific conditions.
Methods
Bacterial strains, plasmids, and growth media
Bacterial strains and plasmids used in this study are
described in Table 3. K. pneumoniae KR116 is a human
blood stream infection isolate obtained from the University
Hospitals of Leicester. Unless otherwise specified, strains
were routinely cultured at 37°C in LB medium supplemen-
ted with 50 μg/ml apramycin, 250 μg/ml ampicillin,
30 μg/ml chloramphenicol, 50 μg/ml kanamycin and/or
15 μg/ml tetracycline for K. pneumoniae, and 100 μg/ml
ampicillin, 12.5 μg/ml chloramphenicol, 50 μg/ml kanamy-
cin and/or 10 μg/ml tetracycline for E. coli.
DNA analysis and manipulations
Restriction enzymes and T4 DNA ligase were obtained
from New England Biolabs and/or Promega and used
according to manufacturer’s instructions. Genomic DNA
and plasmid DNA were extracted using the ArchivePure
DNA Purification Kit (5 PRIME) and GenElute™ Plasmid
Miniprep Kit (Sigma), respectively. Primers used in thisstudy are listed in Additional file 2: Table S1. Standard
PCR amplification was carried out using GoTaq (Promega).
An 8.2 kb region containing the fim2 operon (fim2A-
fim2K) was amplified from KR116 with primers PR937
and PR938 using KOD Hot Start polymerase (Merck),
and cloned into the NotI site of pBluescript II KS + and
pWSK129 to create high (pFim2-HCN) and low copy
number (pFim2-LCN) plasmid clones, respectively. Add-
itionally, the fim2 locus was amplified using primers
PR1224 and PR1222 and was cloned into pJTOOL-7, a
pTRC99a derivative, to create pFim2-Ptrc. A fosmid li-
brary representative of KR116 Δfim2K::kan was con-
structed using the Epicentre Copy Control Fosmid
Library Production kit, with some minor modifications.
Briefly, 2.5 μg of genomic DNA was sheared to
~40 kb fragments by pipetting through a 200 μl tip.
After end repair, the DNA was ligated into pCC2FOS
and packaged into phages using MaxPlax Lambda
Packaging Extracts (Epicentre) which were then used
to infect E. coli EPI300-T1R. Marker rescue of kana-
mycin resistant fosmid clones was performed by plat-
ing infected EPI300-T1R cells on LB plates
supplemented with chloramphenicol and kanamycin.
Selected fosmids were subjected to approximately 60-
fold coverage Roche 454 pyrosequencing (University
of Leicester NUCLEUS Genomics Core Facility).
Construction of mutant strains
K. pneumoniae KR2107, a spontaneous streptomycin-re-
sistant mutant of KR116, was used as the parent strain
for all isogenic mutants. It possessed a 24 h growth
curve identical to KR116 and agglutinated guinea pig
red blood cells in a similar manner. fim2 was exchanged
for a kanamycin resistance cassette by lambda Red-
mediated recombination. KR2107 was transformed with
pKOBEG-Apra, a temperature-sensitive plasmid encod-
ing the lambda Red recombinase system, and grown at
30°C in LB media supplemented with apramycin and
0.2% arabinose. Electrocompetent KR2107/pKOBEG-
Apra cells were prepared according to standard meth-
ods and electroporated with an SOE-PCR product com-
prising a kanamycin resistance gene cassette and
targeting flanking homologous sequences (Additional
file 1: Figure S1). The KR2107Δfim2 mutant was
obtained by selecting on LB media plus kanamycin at
37°C. Loss of pKOBEG-Apra was confirmed by rever-
sion to apramycin sensitivity and a negative PCR with
primers EBGNHe and EBGh3. The KR2107Δfim2 mu-
tant was validated by PCR analysis using primer pairs
PR1103-Kn2 (2590 bp) and Kn1-PR1104 (3903 bp). The
2095 bp Δfim::tet fragment was amplified from
C3091Δfim::tetΔmrk::kan using primers UpfimB-F and
DwfimK-R and electroporated into arabinose-induced
KR2107/pKOBEG-Apra to construct the fim mutant
Table 3 Bacterial strains and plasmids used in this study
Bacterial strain or
plasmid




DH5α F- φ80dlacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK-mK+) phoA supE44
λ- thi-1 gyrA96 relA1
[52]
HB101 F- mcrB mrr hsdS20(rB- mB-) recA13 leuB6 ara-14 proA2 lacY1 galK2 xyl-5 mtl-1
rpsL20(SmR) glnV44 λ-
[53]
CC118λpir Δ(are-leu) araD ΔlacX74 galE galK phoA20 thi-1 rpsE rpoB argE(Am) recA1 λpir [54]
S17-1λpir F’ recA hsdR RP4-2 (Tc::Mu) (Km::Tn7) λpir [55]
EPI300-T1R F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80dlacZΔM15ΔlacX74 recA1 endA1 araD139
Δ(ara-leu)7697 galU galK λ- rpsL nupG trfA tonA dhfr
Epicentre
Klebsiella pneumoniae
C3091 Clinical urinary tract infection isolate; StR [56]
C3091Δfim::tetΔmrk::kan C3091 with fim and mrk clusters deleted; StR, TetR, KanR [23]
KR116 Clinical blood stream infection isolate This work
KR116 Δfim2K::kan KR116 with an insertion-deletion mutation in fim2K where 125 bp has been replaced
by a kanamycin resistance cassette; KanR
This work
KR2107 Spontaneous streptomycin resistant derivative of KR116; StR This work
KR2107Δfim KR2107 with fim deleted; StR, TetR This work
KR2107Δfim2 KR2107 with fim2 deleted; StR, KanR This work
KR2107ΔfimΔfim2 KR2107 with fim and fim2 deleted; StR, TetR, KanR This work
Plasmids
pDS132 Lambda pir-based suicide vector; CmlR [57]
pBluescript II KS+ High copy number cloning vector; AmpR Fermentas
pWSK129 Low copy number cloning vector; KanR [58]
pKOBEG-Apra Lambda Red expression plasmid, PBAD promoter; Apr
R [59]
pRT733 Source of KanR cassette; KanR [60]
pCC2FOS Fosmid cloning vector; CmlR Epicentre
pTRC99a IPTG inducible expression vector with PTRC promoter and lacI
q; AmpR [61]
pJTOOL-7 Derivate of pTRC99a with an added NotI cut site in multiple the cloning site; AmpR This work
pJKO-4a pDS132 with SOE-PCR fragment for tagging of fim2K (fim2K::Kan); CmlR, KanR This work
pJFos-1 40.6 kb fim2K::Kan-containing fragment cloned into pCC2FOS; CmlR, KanR This work
pJFos-4 26.1 kb fim2K::Kan-containing fragment cloned into pCC2FOS; CmlR, KanR This work
pFim2-HCN 9.4 kb PCR fragment containing the fim2 locus cloned into the NotI site of
pBluescript II KS+; AmpR
This work
pFim2-LCN 9.4 kb PCR fragment containing the fim2 locus cloned into the NotI site of pWSK129;
AmpR
This work
pFim2-Ptrc 9.0 kb PCR fragment containing the fim2 locus cloned into the NotI/SbfI site of
pJTOOL-7. IPTG inducible; AmpR
This work
a Amp ampicillin; Apr apramycin; Cml chloramphenicol; Kan kanamycin; St streptomycin; Tet tetracycline. Superscript R indicates resistance.
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a KR2107Δfim/pKOBEG-Apra intermediate strain.
KR116 Δfim2K::kan was constructed by conjugative
transfer of the suicide construct pJKO-4a to facilitate
allelic exchange ([62]; Additional file 1: Figure S1).Transcriptional analysis of fim2
Total RNA was prepared from KR2107 after growing for
16 h in LB liquid medium (37°C, 200 rpm) using the Nor-
gen Total RNA Purification Kit. The Ambion TURBO
DNA-free kit was used to remove residual DNA and cDNA
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scription kit (Qiagen) as recommended by the manufac-
turer. An identical reaction without reverse transcriptase
was performed to assess DNA contamination. Regions cor-
responding to fim2A, fim2H and fim2K were PCR amplified
using primers pairs PR1607-PR1608, PR1609-PR1610, and
PR1611-PR1612, respectively. Regions linking 116met56-10
to fim2A and fim2H to fim2K were detected using primer
pairs PR1626-PR1627 and PR16268-PR1629, respectively.
Amplicons were visualised on 1.5% agarose gels.
Transmission electron microscopy
Five μl of sample was applied to a hydrophilic Formvar-car-
bon coated copper grid (Agar Scientific) and allowed to ad-
sorb for 5 min. After wicking excess liquid, the grid was
washed once using distilled deionised water and then nega-
tive-stained for 15 s with a droplet of 1% uranyl acetate
(pH 4.5). Electron microscopy was performed on a JEOL
JEM-1400 microscope at 80 kV.
Biofilm, growth curve and epithelial adhesion assays
Biofilm assays were performed using a modified microtiter
plate-based method [63]. Briefly, strains were grown for
16 h (37°C, 200 rpm) in LB broth with antibiotics if neces-
sary and subcultured 1:100 into 100 μl LB medium with
0.05 mM IPTG and ampicillin, when required, in 96-well
microtiter plates (Nunc). Plates were incubated statically
for 48 h at 37°C and OD595 (optical density at 595 nm)
readings obtained at the end of incubation. Following in-
cubation the medium was removed and the plate washed
once with distilled water. 125 μl of 0.1% (v/v) crystal violet
was added to each well and left to stain for 10 min. The
plate was then washed twice with distilled water, dried
thoroughly and the stain eluted with 200 μl of 95% ethanol
per well and the absorbance measured at 595 nm (BioRad
Model 680 Microplate reader). Each was strain tested in
eight wells and three replicate experiments were
performed.
Growth curves were performed similarly to biofilm
assays with a few minor modifications. Plates were incu-
bated statically for 24 h at 37°C in a Varioskan (Thermo
Scientific) instrument. The plates were subjected to a brief
vigorous shake every 10 min immediately prior to the ab-
sorbance being measured at 600 nm (OD600). Each strain
was tested in seven wells and two duplicate experiments
were performed.
Quantitative assessment of bacterial adhesion to epithe-
lial cells was performed using human HCT-8 ileocaecal
and 5637 bladder cells. HCT-8 cells were subcultivated
(1:10) twice a week in RPMI 1640 medium containing
25 mM HEPES, 2 mM glutamine, 1 mM pyruvate, 10%
fetal calf serum, 0.002% neomycin and 0.01% streptomycin.
5637 cells were cultivated similarly but no pyruvate was
added to the medium. Epithelial cells were seeded into two24-well tissue culture plates (Nunc) and grown to conflu-
ent monolayers. After carefully washing each well three
times with warm PBS, 1 ml of fresh supplement-free RPMI
1640 was added and inoculated with ~2 × 106 CFU from
an overnight culture. Plates were incubated for 3 h at 37°C.
One plate was then used to determine the total number of
bacteria at the end of 3 h incubation, as described previ-
ously [56]. The wells in the second plate were carefully
washed three times with PBS and then used to determine
the total number of adherent bacteria. All assays were per-
formed in duplicate and repeated independently four
times.
Murine models of infection
Six- to eight-week-old female CFW1 mice (Harlan) were
used for intestinal colonization experiments as described
previously [64]. Briefly, mice were provided with drinking
water containing 5 g/l streptomycin sulphate for 24 h and
fed a 100 μl suspension containing ~109 CFU of each
strain in 20% sucrose. On indicated days, faecal pellets
were collected, weighed and homogenised in 0.9% NaCl
and dilutions plated onto MacConkey agar supplemented
with appropriate antibiotics for faecal CFU counts.
A previously described intranasal infection model was
used in a co-infection format [23]. Six- to eight-week-old
female NMRi mice (Harlan) were anaesthetized and
hooked on a string by their front teeth. 50 μl of bacterial
suspension containing ~5 × 107 CFU of each strain was
dropped onto the nares to allow for aspiration. Mice were
left hooked on the string for 10 min before being returned
to their cages. At sacrifice lungs, spleen and liver were col-
lected in 0.9% NaCl and homogenised. Serial dilutions
were plated on selective media for CFU counts.
The ascending urinary tract infection model in which
C3H mice (Harlan) were inoculated transurethrally with
50 μl of bacterial suspension containing ~5 × 108 CFU
bacteria has been described in detail previously [22,65].
All animal experiments were conducted under the aus-
pices of the Animal Experiments Inspectorate, the Da-
nish Ministry of Justice.
Data analysis, statistics and nucleotide accession number
Nucleotide sequences were annotated and analysed using
the Integrative Services for Genomic Analysis software
and manually curated [66]. The competitive index (CI)
was calculated by dividing the ratio of fim2-positive to
fim2-negative bacteria recovered from infected organs by
the ratio of the corresponding bacteria in the initial inocu-
lum. The non-parametric Mann–Whitney U test was used
to analyse infection data. Biofilm and cell-adhesion data
were analysed using the non-parametric Kruskal-Wallis
test and Dunn’s posthoc analysis. The nucleotide sequence
of KpGI-5 has been deposited online [GenBank:
JN181158].
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